Criteria-wise, breast cancer patients diagnosed under the age of 40, bilateral breast cancer patients, and patients with a personal history of ovarian/pancreatic cancer did not show a statistically significant increase in the number of BRCA1/2 mutation tests. This evidence concerns the gene BRCA1 and breast cancer.